Table 9.
Methodologic considerations
| REGARDS reference—author | Year | Topic |
|---|---|---|
| [7••]—Safford et al. | 2012 | Incidence of very small NSTEMIs and racial disparities |
| [142]—Rizk et al. | 2012 | UMI in the presence of CKD |
| [146]—Levitan et al. | 2013 | UMI and use of preventive medications |
| [148]—Levitan et al. | 2013 | Assessment tool to determine UMI |
| [152•]—Safford et al. | 2013 | Sensitivity of troponin assays and microsize MI |
| [157]—Prineas et al. | 2012 | Racial differences in ECG abnormalities |
| [160]—Prineas et al. | 2014 | LVH and risk of incident CHD |
| [161]—Soliman et al. | 2010 | Calculating Cornell voltage for LVH using non-standard chest electrode |
| [165]—Parmar et al. | 2010 | Unblinded medical record review and outcomes assessment |
| [168]—Halanych et al. | 2011 | Comparing proxy reported and adjudicated determined cause of death |
| [170]—Le et al. | 2014 | Comparing self-reported and directly measured obesity |
| [174]—Thacker et al. | 2014 | Use of claim based algorithms to identify CHD risk |